Arya Vaidya Sala has recently joined hands with M/s. HLL Lifecare Ltd., with the aim of expanding the reach of Ayurvedic medicaments to larger segments of Indian Society. HLL is a mini-ratna Public Sector enterprise with considerable presence in the commercial and social sector segments across the country with a wide range of health care products and services with a focus on maternal and child health. The association between AVS and HLL envisages to utilise the strengths of both partners in such a manner that appropriately selected medicines from the time tested product range of AVS and even some newly developed formulations will be positioned in the Indian Market thru the wide marketing channels of HLL. This programme is expected to serve one of the functional objectives of AVS by enabling the Ayurvedic medicaments to reach segments of Indian Society which had limited access to them until now. It will similarly serve the objective of HLL by filling gaps in the existing product range which will focus at special needs of women’s and child’s health care. A memorandum of understanding was executed between Dr.P.K. Warrier, Managing Trustee, AVS and Shri.M.Ayyappan, Chairman & Managing Director, HLL at Trivandum.

The first product developed and marketed as a part of this association is Lactohil which is a flavoured granular version of the classical medicament Stanyajananarasayanam which is a time tested formulation for enhanced lactation and general health support for new mothers. The product has been positioned thru modern prescription channels by HLL in selected regions of the country. It has been well accepted for its efficacy and easy administration by new mothers and gynecologists based on the PMS data generated from different centres. Lactohil is available in 250 g and 100 g packings with dispensing spoons.

Subsequently, Chyavanules, the granular version of classical Chyavanaprasam devoid of its content of oil, ghee and honey was developed by the Product Development Department of AVS and standardised by the Quality Assurance Department after being authenticated by a Technical Committee. This is particularly suitable for the population in the 40+ age group because it provides all its classical therapeutic effects without the possible risk associated with the use of lipids. And Chyavanules is formulated in a very user-friendly granular form and it is presented in attractive 250 g jars as well as in packets of 20 sachets of 10 g each. This product was launched at a brief public function at Kochi. Both these products are now made available to the public through the Dealership network of AVS too. Other user friendly new products are in the pipe-line to be marketed across the country as part of the AVS-HLL association.